CD8A and neoplasm: Notably, in the tumor microenvironment, Treg cells but not FoxP3−CD4+ or CD8+ T cells have the ability to utilize lactic acid produced by highly glycolytic cancer cells, through MCT1-mediated import, conferring metabolic advantage and survival.